{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:05:27Z","timestamp":1786971927658,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clml.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T08:11:03Z","timestamp":1494490263000},"page":"450-456.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"17","author":[{"given":"Samer A.","family":"Srour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Machiorlatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namali T.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman Z.","family":"Bhutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Selby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara K.","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla D.","family":"Kurkjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2017.05.011_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2017.05.011_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007","volume":"119","author":"Dores","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.011_bib3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.6004\/jnccn.2012.0103","article-title":"Acute myeloid leukemia","volume":"10","author":"O'Donnell","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2017.05.011_bib4","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1002\/cncr.26095","article-title":"Acute myeloid leukemia: how the uninsured fare","volume":"117","author":"Bradley","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.011_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbmt.2007.10.010","article-title":"Costs of allogeneic hematopoietic cell transplantation with high-dose regimens","volume":"14","author":"Saito","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2017.05.011_bib6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2009.01.011","article-title":"Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2017.05.011_bib7","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1200\/JCO.1999.17.7.2244","article-title":"Associations between community income and cancer survival in Ontario, Canada, and the United States","volume":"17","author":"Boyd","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.011_bib8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jnci\/91.16.1409","article-title":"Effects of health insurance and race on early detection of cancer","volume":"91","author":"Roetzheim","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2017.05.011_bib9","first-page":"78","article-title":"Cancer disparities by race\/ethnicity and socioeconomic status","volume":"54","author":"Ward","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2017.05.011_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/cncr.22788","article-title":"The impact of health insurance status on stage at diagnosis of oropharyngeal cancer","volume":"110","author":"Chen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.011_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cncr.22786","article-title":"Insurance status and stage of cancer at diagnosis among women with breast cancer","volume":"110","author":"Halpern","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.011_bib12","first-page":"9","article-title":"Association of insurance with cancer care utilization and outcomes","volume":"58","author":"Ward","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2017.05.011_bib13","first-page":"417","article-title":"Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study","volume":"20","author":"Clegg","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2017.05.011_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1470-2045(08)70032-9","article-title":"Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis","volume":"9","author":"Halpern","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2017.05.011_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1097-0142(20010101)91:1<178::AID-CNCR23>3.0.CO;2-S","article-title":"Disparities in cancer diagnosis and survival","volume":"91","author":"Bradley","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.011_bib16","first-page":"1409","article-title":"Leukemia survival in children, adolescents, and young adults: influence of socioeconomic status and other demographic factors","volume":"20","author":"Kent","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2017.05.011_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/COC.0b013e3181dea934","article-title":"Effects of poverty and race on outcomes in acute myeloid leukemia","volume":"34","author":"Byrne","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.011_bib18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1634\/theoncologist.2011-0126","article-title":"Cancer disparities in the context of Medicaid insurance: a comparison of survival for acute myeloid leukemia and Hodgkin's lymphoma by Medicaid enrollment","volume":"16","author":"Yung","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2017.05.011_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.leukres.2007.07.015","article-title":"Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia","volume":"32","author":"Rodriguez","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2017.05.011_bib20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","article-title":"Access to hematopoietic cell transplantation in the United States","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2017.05.011_bib21","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/cncr.20628","article-title":"Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas","volume":"101","author":"Hwang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2017.05.011_bib22","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.1997.15.7.2644","article-title":"Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factors","volume":"15","author":"Mitchell","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.011_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/1471-2407-10-514","article-title":"Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study","volume":"10","author":"Bhayat","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2017.05.011_bib24","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.011_bib25","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2017.05.011_bib26","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2017.05.011_bib27","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2009.07.023","article-title":"Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation","volume":"15","author":"Baker","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2017.05.011_bib28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1083-8791(01)70018-3","article-title":"The influence of health insurance on outcomes of related-donor hematopoietic stem cell transplantation for AML and CML","volume":"7","author":"Selby","year":"2001","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017300137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265017300137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:28:56Z","timestamp":1761870536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265017300137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2152265017300137"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2017.05.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}